Table 3.
Generalized estimating equation analyses comparing minimal and maximal glucose levels with SEP measures from all SEPs done within the first week of life.
| Minimum glucose (mmol/L) | Maximum glucose (mmol/L) | ||||||
|---|---|---|---|---|---|---|---|
| Value# | 95% CI | P value | Value# | 95% CI | P value | ||
| P16 | Delayed or absent¶ | 0.67 | 0.35 to 1.27 | 0.22 | 1.22 | 0.94 to 1.59 | 0.14 |
| N20 | Delayed or absent¶ | 1.05 | 0.59 to 1.87 | 0.88 | 1.10 | 0.90 to 1.34 | 0.38 |
| P22 | Delayed or absent¶ | 0.62 | 0.38 to 1.00 | 0.05 | 1.10 | 0.93 to 1.31 | 0.25 |
| Amplitude (μV) | 0.09 | 0.01 to 0.17 | 0.03* | 0.00 | −0.02 to 0.02 | 0.98 | |
Analyses adjusted for umbilical arterial cord pH.
CI, confidence interval; SEPs, somatosensory evoked potentials.
P < 0.050.
When comparing glucose levels with delayed or absent SEP waveforms, value represents an odds ratio. When comparing glucose levels with SEP amplitudes, value represents a coefficient.
SEP waveforms were scored as delayed or absent if the waveform was unilaterally or bilaterally prolonged or absent.